Surgery for Ovarian Cancer: 150 Real Stories

150 stories match ovarian cancer and surgery. 121 of them mention chemotherapy.

A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Metastatic Clear Cell Ovarian Cancer Complicated by Treatment-Related Sarcoidosis

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Metastatic Site: peritoneum

During a treatment holiday, biopsy and laboratory evaluation showed treatment-related sarcoidosis rather than ovarian-cancer spread in the enlarged lymph nodes. After prednisone, the sarcoidosis resolved and imaging showed no progression of the clear cell ovarian cancer; she remained clinically well 4 months later.

PubMed Central
OutcomeStable Disease
Christie, who was diagnosed with Ovarian CancerOvarian Cancer

BRCA Ovarian Cancer: Christie's Patient Story

Patient Info: Christie Siebel, female

Biomarkers: BRCA mutation

At the latest update, Christie was doing well and having a CA125 blood test every 3 months for ovarian cancer follow-up.

MD Anderson
OutcomeCare Ongoing
IO
Ovarian Cancer

Immature Ovarian Teratoma Followed by Anti-NMDAR Encephalitis

Patient Info: Anonymized, Female

Biomarkers: AFP 67.6 ng/mL; CA-125 89 at presentation

After 4 cycles of chemotherapy, her neurological deficits fully recovered and she could walk independently, with mild stuttering improving through speech therapy.

PubMed Central
OutcomeNot reported
Shelley, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Shelley's Patient Story

Patient Info: Shelley O’Keefe, female

Shelley was nearing the end of chemotherapy, rebuilding her strength, and returning to demanding golf activity with strong family and community support.

Ovarian Cancer Research Alliance
OutcomeCare Ongoing
Dana, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Dana's Patient Story

Patient Info: Dana Kivel, female

Dana was living with recurrent, metastatic granulosa cell ovarian cancer and taking an aromatase inhibitor for a current tumor.

Ovarian Cancer Research Alliance
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Stage 4 Ovarian Cancer Discovered During Trigeminal Neuralgia Evaluation

Patient Info: Anonymized, Female, 50s | Stage IV

Three months after surgery, she had recovered well from debulking and 6 total chemotherapy cycles, with complete macroscopic clearance achieved at surgery. Trigeminal-neuralgia symptoms persisted and continued to require daily medication.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

MSI-High Malignant Struma Ovarii With Lung and Liver Metastases 17 Years Later

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Biomarkers: NRAS, and ATM mutations; Ki-67 approximately 15%–29%

Metastatic Site: lungs|liver

She remained asymptomatic and tolerated pembrolizumab without obvious adverse effects after 4 doses, with follow-up imaging planned for metastatic lung and liver disease.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Ovarian AdenocarcinomaOvarian Cancer

Rapidly Progressive Stage IIIA2 Ovarian Cancer With Anaplastic Features

Patient Info: Anonymized, Female, Under 40 | Stage Metastatic/Advanced

Biomarkers: CA-125 419 IU/mL; CA19-9 elevated; lactate dehydrogenase elevated

Metastatic Site: lungs|liver

Within 30 days of surgery, the cancer had progressed with a large retroperitoneal nodal mass and new lung and liver metastases. She died from advanced ovarian cancer 5 weeks after surgery.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Ovarian AdenocarcinomaOvarian Cancer

Kidney Complications After Treatment for Stage IV Ovarian Cancer

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: peritoneum|left lymph node

No further ovarian-cancer progression was observed during the 10 months after kidney biopsy. The nephrotic syndrome reached partial remission after immunosuppressive treatment was stopped and supportive care continued.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Aggressive Presumed Ovarian Solid Pseudopapillary Tumor With Widespread Metastases

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|pelvic soft tissue|inguinal lymph…

The disease progressed rapidly across multiple abdominal and nodal sites. She died from disease-related complications 2 months after the oncology consultation while receiving induction chemotherapy.

PubMed Central
OutcomeIn Memory
Lauren, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Lauren's Survivor Story

Patient Info: Lauren Wells, Female, Under 40

Lauren was described as cancer-free and making a strong recovery while continuing physical, occupational, and speech therapy.

Cleveland Clinic
OutcomeCancer-Free / NED
Elle, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Elle's Patient Story

Patient Info: Elle Simone, female

Elle was dealing with an ovarian cancer recurrence while continuing her work and advocacy.

Ovarian Cancer Research Alliance
OutcomeSetback / Progression
Jackie, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III Ovarian Cancer: Jackie's Survivor Story

Patient Info: Jackie Page, Female, 50s | Stage III

In remission with no sign of recurrent disease at the September 2020 publication, while continuing treatment on the clinical trial.

Dana-Farber
OutcomeCancer-Free / NED
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Fibrosarcoma Recurring Rapidly After Debulking Surgery

Patient Info: Anonymized, Female, 40s

Biomarkers: Ki-67 greater than 20%; vimentin diffusely positive; muscle-specific antigen weakly positive

The cancer recurred with a new pelvic mass and ascites 3 months after surgery. Her condition was too poor for chemotherapy, and she died on the second day of palliative hospital care.

PubMed Central
OutcomeIn Memory
Kimberly, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Kimberly's Survivor Story

Patient Info: Kimberly Richardson, 50s

Kimberly described living with no evidence of disease while undergoing frequent tumor-marker surveillance because granulosa cell tumors can recur.

AACR
OutcomeCancer-Free / NED
Jamie, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Jamie's Patient Story

Patient Info: Jamie, female, Under 40

By age 28, Jamie was rebuilding physical strength after two surgeries and had trained as an OCRA peer mentor.

Ovarian Cancer Research Alliance
OutcomeNot reported
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Wilms tumor with early abdominal recurrence

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; residual tumor MyoD1-positive

After 3 months of radiation and a further 3 months of chemotherapy, PET showed no FDG-avid malignancy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Wilms tumor arising in a mature cystic teratoma

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; PAX8-positive

After the diagnosis was revised to ovarian Wilms tumor, she was advised to see a gynecologic oncologist but did not return for follow-up.

PubMed Central
OutcomeNot reported
OC
Ovarian Cancer

Ovarian cancer that later spread to an axillary lymph node

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: axillary lymph nodes

After later peritoneal progression, additional treatment brought the disease to a stable state through her last recorded visit in July 2019.

PubMed Central
OutcomeStable Disease
OC
Ovarian Cancer

Ovarian cancer presenting with axillary lymph-node spread

Patient Info: Anonymized, Female, Under 40 | Stage IV

Metastatic Site: axillary lymph nodes

A 39-year-old woman with high-grade serous ovarian cancer had confirmed spread to an axillary lymph node at diagnosis and underwent extensive cytoreductive surgery.

PubMed Central
OutcomeNot reported
SI
Ovarian Cancer

Stage IV ovarian cancer with axillary lymph-node spread

Patient Info: Anonymized, Female, 50s | Stage IV

Metastatic Site: axillary lymph nodes

A 58-year-old woman with ovarian serous carcinoma and axillary lymph-node spread received chemotherapy, cytoreductive surgery, and postoperative chemotherapy.

PubMed Central
OutcomeNot reported
Patty, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III BRCA1 Ovarian Cancer: Patty's Patient Story

Patient Info: Patty Klein, Female | Stage III

Biomarkers: BRCA1 mutation

Patty was able to continue the olaparib plus BKM120 clinical trial as long as her tumor remained controlled. She later died.

AACR
OutcomeIn Memory